| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enanta Pharmaceuticals Inc (ENTA) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 2 sells. ENTA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.0K | $13.16M | - | |
| Other | 371.4K | $5.70M | - | |
| Other | 38.3K | $588.0K | - | |
| Other | 30.6K | $469.7K | - | |
| Other | 21.8K | $334.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2015 | Luly Jay R.71 | President And CEO | Sell | 15,000 | $50.43 | $756,462.50 | -1.5% |